This guideline covers changing health-damaging behaviours among people aged 16 and over using interventions such as goals and planning, feedback and monitoring, and social support. It aims to help tackle a range of behaviours including alcohol misuse, poor eating patterns, lack of physical activity, unsa...
The microbial causes of pneumonia vary according to its origin and the immune constitution of the patient. Pneumonia is classified into community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP) and pneumonia in the immunocompromised. The guideline development process is guided by its scope - ...
Dans le but d’accroître le nombre d’enfants ayant accès au traitement adapté, la classification et le guide thérapeutique simplifiés de l’OMS pour la prise en charge de la pneumonie de l’enfant dans les établissements de santé de premier niveau et les services de consultation ambulatoire o...
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment. This guideline includes recommendations on: diagno...
La guía trata de temas relacionados al tratamiento de la depresión, tocando temas como: las perspectivas y experiencias de los pacientes con depresión y sus familiares; evaluación y cribado de la depresión; los modelos de atención; tratamiento psicoterapéutico, tratamiento farmacológico; estrateg...
For over 100 years, major epidemics of meningococcal disease have occurred every few years within the African meningitis belt, which runs across the continent from Senegal to Ethiopia. The objectives of this review were to revise WHO guidelines on control of epidemic meningitis in subSaharan Africa conce...
Brotes de Enfermedades,
Meningitis Bacterianas/prevención & control,
Meningitis Bacterianas/tratamiento farmacológico,
África del Sur del Sahara/epidemiología,
Meningitis Bacterianas/diagnóstico,
Meningitis Bacterianas/epidemiología,
Vacunas Meningococicas/administración & dosificación,
Profilaxis Antibiótica/métodos,
Vacunas contra Haemophilus/administración & dosificación,
Juego de Reactivos para Diagnóstico,
Prevalencia,
Incidencia,
Trazado de Contacto
The aim of this guidance is to provide the interim principles that should guide the use of delamanid in conjunction with WHO-recommended MDR-TB treatment. It also specifies the essential treatment and management conditions for use of this drug, in particular the patient's eligibility criteria and safety ...
